Print Issue: March 01, 2007

Adjuvant Radiotherapy Benefits Some

Recent randomized trials have shown that following radical prostatectomy for prostate cancer, adjuvant radiotherapy improves progression-free survival (PFS). Nevertheless, it is possible that some patients with adverse pathological features may be appropriate candidates for delayed salvage radiotherapy.

Ergocalciferol Benefits CKD Patients

Ergocalciferol supplementation in CKD patients can safely raise levels of serum 25-hydroxyvitamin (OH) D levels and decrease serum intact parathyroid hormone (iPTH) levels, especially in patients with stage 4 renal disease.

OTC Drug Use Common in Renal Disease Patients

Use of over-the-counter (OTC) medications and natural remedies is common among patients with moderate or severe chronic renal insufficiency (CRI), and some patients may be using products with contraindicated ingredients, a Canadian study revealed.

Drugs Aid Metastatic RCC Outcomes

Two relatively new oral agents can improve outcomes for patients with metastatic renal cell carcinoma (RCC), according to recent reports. The drugs, sunitinib and sorafenib, inhibit enzymes that promote angiogenesis and thus may act by disrupting tumor vasculature.

Next post in World Literature Review